Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Bone Marrow Transplantation
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
July 1998, Volume 22, Number 2, Pages 207-209
Table of contents    Previous  Abstract  Next   Article  PDF
Case reports
Vancomycin-resistant enterococcal infections in bone marrow transplant recipients
Y Koc1, D R Snydman2, D S Schenkein1 and K B Miller1,a

1Bone Marrow Transplant Unit and the Division of Infectious Diseases, New England Medical Center, Tufts University School of Medicine, Boston, MA, USA

2Department of Medicine and Department of Microbiology, Department of Pathology, New England Medical Center, Tufts University School of Medicine, Boston, MA, USA

aCorrespondence: Dr KB Miller, New England Medical Center, 750 Washington Street, Box No. 245, Boston, MA 02111, USA

Abstract

Vancomycin-resistant enterococci (VRE) infections have been increasingly reported in immunosuppressed individuals over the past decade. Emergence of this pathogen in the bone marrow transplantation (BMT) setting, in the form of bacteremia or positive stool cultures, is of concern because of lack of effective antimicrobial therapy. We report episodes of vancomycin-resistant E. faecium bacteremia in two patients undergoing BMT including the first case of VRE meningitis observed in this setting. Since the outcome in these patients undergoing matched unrelated donor BMT was fatal, we believe that routine screening for VRE in high risk patients should be considered. Management of VRE carrier state in BMT candidates is unclear at present.

Keywords

VRE; bone marrow transplantation; meningitis

Received 19 August 1997; accepted 9 March 1998
July 1998, Volume 22, Number 2, Pages 207-209
Table of contents    Previous  Abstract  Next   Article  PDF
Privacy Policy © 1998 Nature Publishing Group